Bain Capital Life Sciences Investors, LLC Cabaletta Bio, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $312 Million
- Q3 2025
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 9,677,125 shares of CABA stock, worth $22.4 Million. This represents 7.24% of its overall portfolio holdings.
Number of Shares
9,677,125
Previous 9,677,125
-0.0%
Holding current value
$22.4 Million
Previous $14.7 Million
53.29%
% of portfolio
7.24%
Previous 4.41%
Shares
5 transactions
Others Institutions Holding CABA
# of Institutions
83Shares Held
72.8MCall Options Held
1.1MPut Options Held
14.9K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$20.4 Million0.03% of portfolio
-
Jennison Associates LLC8.5MShares$19.6 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.36MShares$19.3 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$11.6 Million1.86% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$11 Million0.0% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $67M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...